Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemamali Samaratunga

Showing results (61-70 of 187) with videos related to

Pageof 19
Sort By:
Pathology|April 17, 2019
Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinomaJulien Dagher, Brett Delahunt, Nathalie Rioux-Leclercq, et al.
Anticancer Research|November 17, 2012
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiationHemamali Samaratunga, Dinithi Samaratunga, Nigel Dunglison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaPDaniel R McCulloch, Pascal Akl, Hemamali Samaratunga, et al.
Histopathology|January 4, 2012
Gleason grading: past, present and futureBrett Delahunt, Rose J Miller, John R Srigley, et al.
Journal of Clinical Pathology|March 13, 2025
Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancersLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 2, 2016
One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason gradingJohn R Srigley, Brett Delahunt, Lars Egevad, et al.
Pathology|February 9, 2025
Gleason scores provide more accurate prognostic information than grade groupsLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Pathology|October 30, 2020
Staging of renal cell carcinoma: current progress and potential advancesBrett Delahunt, John N Eble, Hemamali Samaratunga, et al.
Histopathology|July 22, 2014
Percutaneous renal tumour biopsyBrett Delahunt, Hemamali Samaratunga, Guido Martignoni, et al.
Histopathology|March 19, 2016
Reply: Gleason and Fuhrman no longer make the gradeBrett Delahunt, Lars Egevad, Hemamali Samaratunga, et al.
Pageof 19

Showing results (61-70 of 187) with videos related to

Sort By:
Pageof 19
Pathology|April 17, 2019
Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinomaJulien Dagher, Brett Delahunt, Nathalie Rioux-Leclercq, et al.
Anticancer Research|November 17, 2012
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiationHemamali Samaratunga, Dinithi Samaratunga, Nigel Dunglison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaPDaniel R McCulloch, Pascal Akl, Hemamali Samaratunga, et al.
Histopathology|January 4, 2012
Gleason grading: past, present and futureBrett Delahunt, Rose J Miller, John R Srigley, et al.
Journal of Clinical Pathology|March 13, 2025
Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancersLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 2, 2016
One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason gradingJohn R Srigley, Brett Delahunt, Lars Egevad, et al.
Pathology|February 9, 2025
Gleason scores provide more accurate prognostic information than grade groupsLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Pathology|October 30, 2020
Staging of renal cell carcinoma: current progress and potential advancesBrett Delahunt, John N Eble, Hemamali Samaratunga, et al.
Histopathology|July 22, 2014
Percutaneous renal tumour biopsyBrett Delahunt, Hemamali Samaratunga, Guido Martignoni, et al.
Histopathology|March 19, 2016
Reply: Gleason and Fuhrman no longer make the gradeBrett Delahunt, Lars Egevad, Hemamali Samaratunga, et al.
Pageof 19